Evolent Health

Evolent Health, Inc. engages in the provision of health care delivery and payment services. It deals with population health management, health plan and third party administration, network performance and pharmacy benefit management, risk adjustment, analytics and performance improvement, and technology and electronic medical record integration. The firm operates through Services and True Health segments. The Services segment includes clinical and administrative solutions such as total cost of care management and specialty care management and comprehensive health plan administrative services. The True Health segment offers a physician-led health plan for employer-sponsored health coverage. The company was founded by Frank J. Williams, Seth B. Blackley, and Thomas Peterson III in August 2011 and is headquartered in Arlington, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Evolent Health excels in Q4 2022, eyes growth with Humana

Evolent Health posts strong financials, exceeding revenue and EBITDA targets.
Strategic partnerships and focus on organic growth drive value creation.
Challenges lie in maintaining growth momentum and effective execution.
Opportunities include margin expansion, capital optimization, and Humana partnerships.

Evolent Health surpasses Q1 expectations, eyes revenue growth opportunities

Evolent Health's Q1 performance exceeded expectations, driven by strong revenue growth and margin expansion initiatives. While facing challenges like revenue adjustments and Medicaid rebates, the company remains focused on capitalizing on growth opportunities through strategic partnerships and operational efficiencies.

Evolent Health excels in Q2, eyes $300M EBITDA target

Evolent Health's robust performance in Q2, strategic partnerships, and focus on organic growth position it well to achieve its financial targets.
Challenges lie in Medicaid membership declines, capital allocation optimization, and refinancing decisions amidst market uncertainties.
Opportunities in patient-centric care, CMS changes, and integrated entity approach offer avenues for growth and differentiation in the market.

Evolent Health surpasses Q3 expectations, eyes growth in specialty care

Evolent Health's Q3 performance exceeded expectations, driven by strong revenue growth and profitability, underpinned by strategic partnerships and a unique care model.
Despite challenges in ramping up Performance Suite adoption and maintaining cost control, the company's focus on growth and value creation positions it well for future success.
Opportunities in expanding specialty offerings and leveraging new partnerships highlight Evolent's growth potential and commitment to delivering value in the healthcare sector.

Evolent Health exceeds 2023 targets, eyes growth through partnerships

Evolent Health delivered strong financial results in Q4 2023, surpassing its 2023 targets and setting ambitious goals for 2024, driven by Specialty Care offerings and new revenue agreements.
While facing challenges related to medical utilization and new product launches, the company remains focused on organic growth and profitability, supported by a strategic approach to expansion.
Opportunities in cross-selling, new state expansions, and imaging capabilities position Evolent Health for continued growth and revenue diversification in the healthcare sector.

Evolent Health reports robust Q1 earnings, eyes margin improvements

Evolent Health's Q1 performance showcased strong revenue growth and EBITDA in line with guidance.
The company is optimistic about margin improvements, revenue expansion, and maintaining a balanced pipeline.
Challenges include margin impact from new go-lives and ongoing payer negotiations amid cost pressures.
Opportunities lie in improving gross margins, leveraging population changes, and focusing on cash flow expectations.

Evolent Health reports robust Q2 earnings, eyes growth opportunities ahead

Evolent Health's Q2 2024 earnings call highlighted strong financial performance, strategic initiatives, and a positive outlook for future growth. The company's focus on revenue diversification, margin optimization, and disciplined financial management positions it well for continued success in the evolving healthcare landscape.

Evolent Health revises outlook after Q3 challenges, secures financing

Evolent Health navigated higher medical costs impacting Q3 results, leading to a revised outlook for 2024. Despite challenges in managing expenses and oncology costs, the company remains committed to growth and securing new revenue agreements.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Evolent Health, Inc. engages in the provision of healthcare delivery and payment services. It deals with population health management, health plan and third party administration, network performance and pharmacy benefit management, risk adjustment, analytics and performance improvement, and technology and electronic medical record integration. The firm operates through Services and True Health segments. The Services segment includes clinical and administrative solutions such as total cost of care management and specialty care management and comprehensive health plan administrative services. The True Health segment offers a physician-led health plan for employer-sponsored health coverage. The company was founded by Frank J. Williams, Seth B. Blackley, and Thomas Peterson III in August 2011 and is headquartered in Arlington, VA.

The mean of analysts' price targets for Evolent Health (EVH) points to a 37.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Wall Street Analysts Believe Evolent Health (EVH) Could Rally 38%: Here's is How to Trade

Wilmington, Delaware--(Newsfile Corp. - May 27, 2022) - Rigrodsky Law, P.A. is investigating potential claims against the officers and directors of Evolent Health, Inc. (NYSE: EVH) on behalf of stockholders.To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-evolent-health-inc.To contact Seth D. Rigrodsky or Gina M. Serra cost free, call or text (302) 295-5310 or email info@rl-legal.com.Rigrodsky Law, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on...

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Evolent Health, Inc.

The consensus price target hints at a 38.6% upside potential for Evolent Health (EVH). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Can Evolent Health (EVH) Climb 39% to Reach the Level Wall Street Analysts Expect?

WASHINGTON , May 9, 2022 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent"), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced that Chief Executive Officer Seth Blackley, Chief Financial Officer John Johnson and Vice President, Investor Relations Seth Frank will participate in upcoming investor conferences. A live audio-only webcast and replay for the events below will be available on the Investor Relations section of Evolent's website at http://ir.evolenthealth.com/, unless otherwise stated.

Evolent Health to Participate in Upcoming Investor Conferences

Evolent Health, Inc. (NYSE:EVH ) Q1 2022 Earnings Conference Call May 4, 2022 5:00 PM ET Company Participants Seth Blackley – Chief Executive Officer John Johnson – Chief Financial Officer Seth Frank – Vice President of Investor Relations Conference Call Participants Richard Close – Canaccord Genuity Ryan Daniels – William Blair Anne Samuel – JPMorgan Charles Rhyee – Cowen Jessica Tassan – Piper Sandler David Larsen – BTIG Sandy Draper – Guggenheim Operator Welcome to Evolent Health's Earnings Conference. Call for the first quarter ended March 30, 2022.

Evolent Health, Inc. (EVH) CEO Seth Blackley on Q1 2022 Results - Earnings Call Transcript

Announces Two Operating Partner Additions and One Expansion WASHINGTON , May 4, 2022 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced financial results for the quarter ended March 31, 2022. Highlights from the first quarter of 2022 announcement include: Quarter ended March 31, 2022: GAAP revenue of $297.1 million, an increase of $82.0 million, or 38.1%, from the three months ended March 31, 2021.

Evolent Health Announces First Quarter 2022 Results

WASHINGTON , April 18, 2022 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced it will release its first quarter 2022 operating results on Wednesday, May 4, 2022 after market close, with a conference call to follow at 5:00 p.m. Eastern Time.

Evolent Health, Inc. to Release First Quarter Operating Results and Host Conference Call on Wednesday, May 4, 2022

In an SEC filing, Cook County named Evolent Health Inc (NYSE: EVH) the sole third-party administrator for CountyCare Health Plan from fiscal 2023 through fiscal 2025. Piper Sandler analyst Jessica Tassan notes that the award extends a contract Evolent has held since fiscal 2018 to.

Evolent Health 'Notification Award' Removes $82M Overhang, Notes Piper Sandler

Evolent Health recently reported their Q4/2021 earnings that revealed a solid beat on EPS and revenue. In addition, the company updated investors on their bullish outlook for 2022.

Evolent Health: Finding Steady Growth At An Acceptable Valuation

The company's stock climbed nearly $5 higher per share on Thursday over its closing price on Wednesday.

Why Shares of Evolent Health Jumped 22% Thursday

Evolent Health, Inc. (EVH) CEO Seth Blackley on Q4 2021 Results - Earnings Call Transcript

WASHINGTON, Feb. 23, 2022 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced financial results for the quarter and full year ended December 31, 2021. Highlights from the fourth quarter and full year 2021 announcement include (all comparisons are to the quarter and full year ended December 31, 2020): Quarter ended December 31, 2021: GAAP revenue of $248.4 million, an increase of $1.8 million, or 0.7%, from the three months ended December 31, 2020.

Evolent Health Announces Fourth Quarter and Full Year 2021 Results

WASHINGTON, Jan. 27, 2022 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced that it has been recognized as a Best Place to Work for LGBTQ+ Equality by the Human Rights Campaign (HRC) Foundation for 2021. This is the second consecutive year that Evolent has earned the designation by scoring 100% on HRC's Corporate Equality Index (CEI), the nation's foremost benchmarking survey and report measuring corporate policies and practices related to LGBTQ+ workplace equality.

Evolent Health Named One of the Best Places to Work for LBGTQ+ Equality for Second Consecutive Year

WASHINGTON , Jan. 25, 2022 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced it will release its fourth quarter and full year 2021 operating results on Wednesday, February 23, 2022 after market close, with a conference call to follow at 5:00 p.m. Eastern Time.

Evolent Health, Inc. to Release Fourth Quarter and Full Year 2021 Operating Results and Host Conference Call on Wednesday, February 23, 2022

WASHINGTON, Jan. 24, 2022 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced that it has partnered with a minority-owned business, PCG Consulting Group (PCG), to launch a new customer contact team in Cook County, Ill., which will support more than 400,000 Medicaid health plan members there.

Evolent Health Partners with Minority-Owned Business to Support Medicaid Plan Operations in Cook County, Ill.

WASHINGTON, Dec. 14, 2021 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent"), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced that Chief Executive Officer and Co-Founder Seth Blackley and Chief Financial Officer John Johnson will participate in an upcoming investor conference. Mr. Blackley and Mr.

Evolent Health to Participate in Upcoming Investor Conference

WASHINGTON, Dec. 1, 2021 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent"), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced that Seth R. Frank has joined the company as Vice President, Investor Relations, effective immediately.

Evolent Health Appoints Seth R. Frank as Vice President, Investor Relations

WASHINGTON, Nov. 16, 2021 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent"), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced that Chief Financial Officer John Johnson will host a panel, "Evolent Health Spotlight: New Century Health - Oncology Care Reimagined," on Thursday, November 18 from 12-1pm ET. The panel will feature physicians from Evolent Health's subsidiary, New Century Health, as well as several New Century Health partners who will share their perspectives on advancing oncology care.

Evolent Health to Host Oncology Care Panel on Thursday, November 18, 2021

Evolent Health, Inc.'s (EVH) CEO Seth Blackley on Q3 2021 Results - Earnings Call Transcript

Evolent Health (EVH) delivered earnings and revenue surprises of 0.00% and -1.64%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Evolent Health (EVH) Reports Q3 Loss, Misses Revenue Estimates

WASHINGTON, Nov. 3, 2021 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced that it will provide comprehensive advanced care planning services through its specialty management offering New Century Health to Health New England, a not-for-profit provider-owned health plan based in Massachusetts that serves 180,000 members. New Century Health will support Health New England's Medicaid, Medicare and Commercial members through its Vital Decisions platform.

Evolent Health's Subsidiary New Century Health to Support Health New England With Comprehensive Advance Care Planning Services

WASHINGTON, Nov. 3, 2021 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced that Dr. Tunde Sotunde MD, MBA, FAAP has been appointed to its Board of Directors. Dr. Sotunde has more than 20 years' experience in the health care industry and currently serves as President and Chief Executive Officer of Blue Cross and Blue Shield of North Carolina, North Carolina's largest insurer which provides coverage to more than 4.2 million members.

Evolent Health Elects Dr. Tunde Sotunde MD, MBA, FAAP to Board Of Directors

WASHINGTON, Nov. 3, 2021 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced financial results for the quarter ended September 30, 2021. Highlights from the third quarter of 2021 announcement include: Quarter ended September 30, 2021: GAAP revenue of $222.5 million, a decrease of $17.1 million, or 7.1%, from the three months ended September 30, 2020.

Evolent Health Announces Third Quarter 2021 Results

Evolent Health (EVH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Evolent Health (EVH) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

WASHINGTON, Oct. 18, 2021 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced it will release its third quarter 2021 operating results on Wednesday, November 3, 2021 after market close, with a conference call to follow at 5:30 p.m. Eastern Time.

News for Evolent Health Stock (EVH)